Michael M I Abecassis

15PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersAllergyGene and molecular therapyTransplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 12, 2021
Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.

Josh Levitsky, Manoj Kandpal, Kexin Guo

|Jul 14, 2020
Acute murine cytomegalovirus disrupts established transplantation tolerance and causes recipient allo-sensitization.

Shuangjin Yu, Anil Dangi, Melanie Burnette

|Feb 25, 2020
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.

Roslyn B Mannon, Randall E Morris, Michael Abecassis

|Apr 05, 2019
A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Zheng Zhang, Longhui Qiu, Shixian Yan

|Dec 02, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.

Riad Salem, Ahmed Gabr, Ahsun Riaz

|May 17, 2017
Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients.

T K Toby, M Abecassis, K Kim

Pageof 3

Frequent Collaborators

5 joint publications

John J Friedewald

1 joint publications

Riad Salem

1 joint publications

Ahmed Gabr

1 joint publications

Roslyn B Mannon